Viking Therapeutics (VKTX) Non-cash Items (2015 - 2026)

Viking Therapeutics has disclosed Non-cash Items across 12 years of filings, most recently posting $3.8 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $3.8 million, up 31.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (up 31.12% YoY), and the FY2025 annual result was $114.0 million, down 19.32% from the prior year.
• Non-cash Items came in at $3.8 million for Q1 2026 at Viking Therapeutics, down from $114.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $23.3 billion in Q3 2023 to a low of $1.1 million in Q3 2022.
• The 5-year median for Non-cash Items is $20.5 million (2022), against an average of $1.4 billion.
• Across the five-year window, Non-cash Items surged 2073855.56% in 2023 and plunged 99.28% in 2025, its largest moves.
• Viking Therapeutics' Non-cash Items stood at $20.5 million in 2022, then surged by 203.24% to $62.2 million in 2023, then jumped by 127.13% to $141.3 million in 2024, then fell by 19.32% to $114.0 million in 2025, then sank by 96.66% to $3.8 million in 2026.
• The last three Non-cash Items figures came in at $3.8 million (Q1 2026), $114.0 million (Q4 2025), and $75.0 million (Q3 2025), per Business Quant data.